-
NMPA Announcement on Adopting ICH Guidelines M10 Q&As and FAQs
2023-07-04
To align the technical standards for drug registration with international standards, the NMPA upon deliberation decided to adopt the ICH(International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use) Guidelines M10: Bioanalytical Method Validation And Study Sample Analysis (hereinafter referred to as M10) Q&As documents and FAQs documents.
-
Special Provisions for TCM Registration released
2023-02-10
On Feb 10, the Special Provisions for Traditional Chinese Medicines Registration (hereinafter referred to as the Special Provisions) is issued by China NMPA and will take effect on July 1, 2023.
-
Provisions for Supervision and Administration of Online Drug Sales
2022-12-29
Promulgated by Decree No. 58 of the State Administration for Market Regulation on August 3, 2022, these Provisions shall go into effect as of December 1, 2022.
-
Provisions for Supervision and Administration of Manufacturing and Marketing of Cosmetics
2022-10-25
(Promulgated by Decree No. 46 of the State Administration for Market Regulation on August 2, 2021, these Provisions shall be effective as of January 1, 2022.)
-
Provisions for Administration of Medical Device Recall
2022-10-25
Promulgated by Decree No. 29 of the China Food and Drug Administration on January 25, 2017, these Provisions shall be effective as of May 1, 2017.
